Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,281 | 1,972 | 354 | 3,110 | 673 |
| Marketable Securities | 5,810 | 7,775 | 11,426 | 10,486 | 14,574 |
| Receivables | 1,413 | 1,393 | 1,435 | 1,506 | 1,238 |
| TOTAL | $9,839 | $11,579 | $13,523 | $15,496 | $16,985 |
| Non-Current Assets | |||||
| PPE Net | 1,219 | 1,115 | 1,167 | 1,235 | 1,313 |
| Other Non-Current Assets | 174 | 177 | 209 | 283 | 281 |
| TOTAL | $1,393 | $1,292 | $1,376 | $1,518 | $1,594 |
| Total Assets | $11,232 | $12,871 | $14,899 | $17,014 | $18,579 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 943 | 626 | 553 | 697 | 701 |
| Accrued Expenses | 1,564 | 1,804 | 1,403 | 2,163 | 1,551 |
| TOTAL | $2,507 | $2,430 | $1,956 | $2,860 | $2,252 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,507 | $2,430 | $1,956 | $2,860 | $2,252 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 316 | 315 | 315 | 313 | 313 |
| Common Shares | 99,170 | 99,137 | 99,031 | 250 | 98,895 |
| Retained earnings | -90,426 | -88,683 | -86,075 | -84,819 | -82,562 |
| Other shareholders' equity | -19 | -13 | -13 | -16 | -6 |
| TOTAL | $8,725 | $10,441 | $12,943 | $14,154 | $16,327 |
| Total Liabilities And Equity | $11,232 | $12,871 | $14,899 | $17,014 | $18,579 |